Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
TELAthis companyTELA Bio, Inc.	$0.89	-1.42×	8.78×	0.69×	-1.86×	61.9%	67.7%	-42.0%	-48.4%	-615.1%	-53.2%	-51.7%	8.82×	-0.15×	-6.44×	4.2×	0.0%	3	-9.39	2	B-
CTSOCytosorbents Corporation	$5.55	-4.92×	6.74×	1.07×	-14.38×	-2821.3%	71.5%	-38.4%	-22.1%	-138.9%	-38.8%	-31.5%	4.93×	-5.25×	-5.45×	2.13×	0.0%	4	-12.29	2	C
CUECue Biopharma, Inc.	$19.50	-1.09×	1.09×	1.05×	-0.24×	-850.1%	100.0%	-96.6%	-96.9%	-100.6%	-86.6%	-75.6%	0.16×	0.93×	-74.29×	2.74×	0.0%	2	-30.14	1	D+
EQEquillium, Inc.	$1.59	-3.97×	4.98×	0×	-5.06×	-77.1%	0.0%	0.0%	0.0%	-78.3%	-83.3%	-16.0%	0.03×	1.33×	0×	10.32×	0.0%	1	14.51	2	C
MDAISpectral AI, Inc.	$1.55	-4.9×	-6.58×	1.92×	-5.97×	-468.4%	45.4%	-43.8%	-38.5%	132.2%	-197.0%	-26.3%	-1.76×	0.98×	-5.71×	0.94×	0.0%	1	-4.49	2	C
NRXPNRx Pharmaceuticals, Inc.	$2.42	-2.02×	-3.64×	47.35×	-1.83×	-67.8%	58.8%	-1324.4%	-2336.5%	179.6%	106.0%	-24.3%	-0.04×	0.26×	-24.18×	0.31×	0.0%	4	-13.9	2	C+
Peer median	—	-3.97×	1.09×	1.07×	-5.06×	-468.4%	58.8%	-43.8%	-38.5%	-78.3%	-83.3%	-26.3%	0.03×	0.93×	-5.71×	2.13×	0.0%	2	-12.29	2	—